Table 2.
The results of CTC, CTEC, CEA, and CA19-9 levels between CRC patients and controls.
| Groups | CRC patients (n = 115) | Controls (n = 20) | P value | Sensitivity | Specificity |
|---|---|---|---|---|---|
| CTCs | <0.001 | 0.878 | 0.900 | ||
| Positive | 101 (87.8%) | 2 (10.0%) | |||
| Negative | 14 (12.2%) | 18 (90.0%) | |||
| CTECs | <0.001 | 0.391 | 1 | ||
| Positive | 45 (39.1%) | 0 (0%) | |||
| Negative | 70 (60.9%) | 20 (100%) | |||
| CEA | 0.004 | 0.287 | 1 | ||
| Positive | 33 (28.7%) | 0 (0%) | |||
| Negative | 82 (71.3%) | 20 (100%) | |||
| CA19-9 | 0.044 | 0.261 | 0.950 | ||
| Positive | 30 (26.1%) | 1 (5.0%) | |||
| Negative | 85 (73.9%) | 19 (95.0%) |
CTC and CTEC positive: ≥1 CTC/7.5 mL, CEA positive: >10.9 ng/mL, and CA19-9: >37 U/mL.